Effects of periconceptional folate on cognition in children of women with epilepsy
NEAD study
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 8, 2019
- Accepted in final form August 21, 2019
- First Published December 23, 2019.
Article Versions
- Previous version (December 23, 2019 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Kimford J. Meador, MD,
- Page B. Pennell, MD,
- Ryan C. May, PhD,
- Carrie A. Brown, MS,
- Gus Baker, PhD,
- Rebecca Bromley, PhD,
- David W. Loring, PhD,
- Morris J. Cohen, EdD;
- for the NEAD Investigator Group
- Kimford J. Meador, MD,
NONE
NONE
NONE
Dr. Meador is on the editorial boards for Neurology, Cognitive & Behavioral Neurology, Epilepsy & Behavior, and Epilepsy & Behavior Case Reports.
NONE
NONE
NONE
Dr. Meador has acted as a consultant for the Epilepsy Study Consortium that receives money from multiple pharmaceutical companies; Dr. Meador has received salary support to his university from the Epilepsy Consortium for research consultant work related to Eisai, GW Pharmaceuticals, NeuroPace, Novartis, Supernus, Upsher-Smith Laboratories, UCB Pharma and Vivus Pharmaceuticals. In addition, he is Co-I and Director of Cognitive Core of the Human Epilepsy Project for the Epilepsy Study Consortium.
NONE
Dr. Meador received travel support from UCB Pharma.
Clinical care of patients with epilepsy.
Dr. Meador received grant research support from Sunovion Pharma.
Dr. Meador is receiving active research support for NIH/NINDS 2-U01- NS038455-16 Meador (Multi-PI) Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs and for NIH/NINDS # R01NS088748.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Page B. Pennell, MD,
NONE
NONE
Travel has been reimbursed by the the American Epilepsy Society, Epilepsy Foundation, and the National Institutes of Health.
NONE
NONE
NONE
NONE
NONE
NONE
National Institutes of Health, grant reviews.
NONE
NONE
1) NIH (NINDS and NICHD) grants #U01 NS038455, multiple Principal Investigator, 2014-present.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Ryan C. May, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
1)The Emmes Company, LLC, Senior Biostatistician Manager, 8 years
NONE
NONE
NONE
NONE
1) The Emmes Company, LLC
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Carrie A. Brown, MS,
NONE
NONE
NONE
NONE
NONE
NONE
(1) Emmes, biostatistician, 2 years
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Gus Baker, PhD,
Sanofi Aventis 2009- Advising on research investigating the neurodeveolmental effects of AED treatment. UCB 2009 - Principal investigator for study investigating neurodevelopmental effects of treatment of AED treatment Epilepsy Research UK 2010 - Principal investigator for study investigating neurodevelopmental effects of treatment of novel AED treatment
NONE
Funding to present research at the ILAE UK meeting UCB 2012 Expert witness for class action involving the production of an unsafe drug by Sanofi Aventis 2015
Editorial Board of Epilepsy and Behaviour 2002 - Editorial Board for Seizure 2000 - Editorial Board for Epilepsy Research 2002
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Educational Grant from UCB Pharma [PI] 2009 - 2010 Educational Grant from Sanofi Aventis [PI] 2005 - 2010 Educational Grant from Pfizer [PI] 2008-2010 Educational Grant from ERUK 2009-
NONE
NONE
Epilepsy Research UK 2009-2011 Principal Investigator Medical Research Council 2009-2011 Co-Prinicipal Investigator Epilepsy Action UK Principal Investigator 2009-2011
NONE
NONE
NONE
NONE
NONE
NONE
- Rebecca Bromley, PhD,
During the period of this study I gave two presentations to advisory boards for Sanofi Aventis. I was paid for these ($1000.00 in total) but this money went to my hospital or to charity.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
During the period of this study I worked on another study where my salary was supported through an educational grant from Sanofi Aventis.
NONE
NONE
Epilepsy Research UK.
NONE
NONE
NONE
NONE
NONE
I provided expert testimony regarding fetal valproate syndrome in the UK; although this case did not go to court.
- David W. Loring, PhD,
Professional Advisory Board, Epilepsy Foundation
NONE
Received travel expenses and honoraria for educational activities funded by NeuroPace.
1. Neuropsychology Review, Editor in Chief, 2015- 2. Epilepsia, Associate Editor, 2013- 3. Archives of Clinical Neuropsychology, Editorial Board, 2016
NONE
Lezak MD, Howieson DB, Loring DW. Neuropsychological Assessment. 4th ed. New York: Oxford University Press, 2004 Loring DW, ed. INS dictionary of neuropsychology and clinical neurosciences (2nd edition). New York: Oxford University Press, 2015
NONE
NeuroPace, consultant
NONE
NONE
Neuropsychological Testing - 90%
NONE
1 R01 MH118514-01 National Neuropsychological Network (NNN) 03/04/2019 Â 01/31/2024 Site PI 2U01NS038455-16A1 Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) 05/15/2018 - 02-28-2023
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Morris J. Cohen, EdD;
NONE
NONE
NONE
NONE
NONE
Children's Memory Scale, The Psychological Corporation, Pearson, 1997 to present.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- for the NEAD Investigator Group
- From the Department of Neurology and Neurological Sciences (K.J.M.), Stanford University, CA; Department of Neurology (P.B.P.), Brigham and Women's Hospital, Harvard Medical School, Boston; The Emmes Corporation (R.C.M., C.A.B.), Rockville, MD; Walton Centre for Neurology & Neurosurgery (G.B.), University of Liverpool, Merseyside; Division of Evolution and Genomic Science (R.B.), School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, UK; Departments of Neurology and Pediatrics (D.W.L.), Emory University, Atlanta; and Pediatric Neuropsychology International (M.J.C.), Augusta, GA.
- Correspondence
Dr. Meador kmeador{at}stanford.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Effects of fetal antiepileptic drug exposureOutcomes at age 4.5 yearsK.J. Meador, G.A. Baker, N. Browning et al.Neurology, April 04, 2012 -
Articles
Effects of breastfeeding in children of women taking antiepileptic drugsK.J. Meador, G.A. Baker, N. Browning et al.Neurology, November 24, 2010 -
Article
IQ at 6 years after in utero exposure to antiepileptic drugsA controlled cohort studyGus A. Baker, Rebecca L. Bromley, Maria Briggs et al.Neurology, December 24, 2014 -
Articles
In utero antiepileptic drug exposureFetal death and malformationsK. J. Meador, G. A. Baker, R. H. Finnell et al.Neurology, August 07, 2006